advertisement
Kodjikian L 12
Showing records 1 to 12 | Display all abstracts from Kodjikian L70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Malclès A
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70477 Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial
Chiquet C; Aptel F
American Journal of Ophthalmology 2017; 174: 76-84
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Dot C; Voirin N
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70477 Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial
Creuzot-Garcher C
American Journal of Ophthalmology 2017; 174: 76-84
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Vié AL
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70477 Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial
Berrod JP
American Journal of Ophthalmology 2017; 174: 76-84
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Agard É
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70477 Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial
Kodjikian L; Massin P
American Journal of Ophthalmology 2017; 174: 76-84
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Bellocq D; Denis P
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70477 Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial
Deloche C; Perino J
American Journal of Ophthalmology 2017; 174: 76-84
70402 SAFETY OF INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX): The SAFODEX study. Incidence and Risk Factors of Ocular Hypertension
Kodjikian L
Retina (Philadelphia, Pa.) 2017; 37: 1352-1359
70477 Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial
Kirwan BA; de Brouwer S; Combette JM; Behar-Cohen F
American Journal of Ophthalmology 2017; 174: 76-84
